Clinical Trial Update: Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying adoptive transfer of tumor-infiltrating lymphocytes for metastatic uveal melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Tumor-infiltrating lymphocytes (TIL) therapy

Snippet

Sponsor: Udai Kammula | Conditions: Uveal Neoplasms, Melanoma, Uveal | Phase 2 | Status: RECRUITING